Author

Shilpa Sanapala

Washington University in St. Louis

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Daniel E. AsarnowiD· 1 shared David A. BakeriD· 1 shared David VeesleriD· 1 shared Jack T BrowniD· 1 shared James Brett CaseiD· 1 shared Jimin LeeiD· 1 shared Lauren P. CarteriD· 1 shared M. Alejandra TortoriciiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

Daniel E. AsarnowORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A pan-variant miniprotein inhibitor protects against SARS-CoV-2 variants

Jimin Lee, James Brett Case, Young‐Jun Park, Rashmi Ravichandran, Daniel E. Asarnow, M. Alejandra Tortorici, Jack T Brown, Shilpa Sanapala, Lauren P. Carter, David A. Baker, Michael S. Diamond, David Veesler

This paper describes a miniprotein inhibitor that neutralizes multiple SARS-CoV-2 variants and protects mice against them when administered post-exposure.

Communications Biology · Jan 10, 2026Peer-reviewedBiochemistry